Teams at the Peninsula Medical School in Truro at the Royal Cornwall Hospital and The Christie in Manchester have already had some success with the treatment of vulval cancer and Paget’s disease – the pre-cancer - that does away with the need for surgery. The complete eradication of the cancer has been possible.

This work has been entirely experimental so far, yet the teams in both hospitals are keen to secure the funding to develop this work into a full clinical trial

The charity is keen to support them, and we need an initial £100,000 to get the Phase 1 study formally approved by the regulators and other medical bodies, and get the first 12 patients treated.

We hope that members of the public will be keen to contribute. You can do so from this website.

The charity has a number of fund raising priorities for the development of PDT for women’s cancers, and these include breast, ovarian and cervical, plus PDT as an alternative to hysterectomy.

The intention is to fund this trial jointly with the drug owners and for KILLING Cancer’s commercial team to negotiate a commercial relationship where a percentage of future drug sales revenue is returned to the charity to re-invest in the development of other cancer treatments.

This new Vulval and Paget’s trial will be conducted jointly in the UK, Europe and North America.

The start date for any full trial is likely to be December 2009 – funds permitting.

This website will carry updates on the future plans for this trial and ways that patients can volunteer to take part in the different phases of the trial.

Unlike some of the other PDT treatments you will have seen discussed on this website, this treatment is expected to use a PDT cream that should avoid any ‘whole body’ light sensitive issues.